A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Kepler Vision Technologies Unveils Innovative Kepler Night Nurse Lying Position Detection to Combat Pressure Ulcers

Kepler Vision Technologies, a pioneering leader in healthcare AI solutions, is proud to introduce its ground-breaking feature, the Kepler Night Nurse Lying Position Detection. This innovative technology, offers a powerful solution to the pressing issue of pressure ulcers, commonly known as bedsores.

Pressure ulcers pose a significant threat to patients, with statistics indicating that over 60 percent of patients face the risk of developing these painful sores, with approximately 250 people losing their lives each year due to complications arising from pressure ulcers, according to recent research.

The Kepler Night Nurse Lying Position Detection augments the existing suite of features, including fall detection and prevention modules. This new addition is designed to empower healthcare professionals in their tireless efforts to prevent and mitigate the occurrence of bedsores.

Pressure ulcers result from various factors, primarily prolonged pressure on the skin or shearing forces. Vulnerable patients include elderly residents in nursing homes and individuals recovering from surgery who are confined to their beds. Given that pressure ulcers often heal slowly and are prone to recurrence, prevention is paramount.

Healthcare providers employ multiple interventions to avert pressure ulcers, with repositioning patients as a central strategy. Additionally, healthcare staff assess mattress suitability and maximize bed capabilities. However, these interventions demand considerable time and attention from healthcare workers. Some patients are unable to change positions independently, potentially disrupting their vital sleep, leading to fatigue and restlessness.

The Kepler Night Nurse Lying Position Detection empowers healthcare professionals with critical information about patients at an elevated risk of developing pressure ulcers. By continuously monitoring patients’ sleep positions, the Kepler module offers timely insights, indicating when manual position adjustments are required.

This revolutionary feature not only saves a significant amount of time—manual patient turning can take up to 20 minutes and must occur every 2 to 4 hours—but also reduces healthcare costs. The financial burden associated with caring for patients with pressure ulcers ranges from tens to hundreds of euros per patient per day, depending on the severity of the condition.

Kepler Vision Technologies is dedicated to transforming healthcare by leveraging advanced AI solutions, and the Kepler Night Nurse Lying Position Detection is a testament to the commitment to enhancing patient care, alleviating the workload of healthcare professionals, and ultimately improving the quality of life for those under their care.


Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.
“We are excited to present the first look at the safety and clinical activity of ELVN-001, which we believe supports the potential for ELVN-001 to address the limitations of the available active-site TKIs,” said Helen Collins, M.D., Chief Medical Officer of Enliven. “Across a wide dose range, ELVN-001 demonstrated activity in a heavily pre-treated patient population that includes post-asciminib patients, with a preliminary safety profile consistent with its highly selective design. Not only did all evaluable patients have improved or stable BCR::ABL1 transcript levels, but, importantly, 89% of all patients enrolled remain on study. We believe the initial data demonstrate the potential clinical utility of ELVN-001 for all types of patients, including those that are earlier in the treatment paradigm.”
The partnership is with Health-HavenRx ™, an online pharmacy platform. This partnership enables a new, convenient channel for patients to access POGO Automatic by using their health insurance on Intuity Medical’s e-commerce website at www.GoodtoPogo.com.

By using this website you agree to accept Medical Device News Magazine Privacy Policy